Protected guide RNAs (pgRNAs)
US-12571005-B2 · Mar 10, 2026 · US
This page is not indexed by search engines while we improve data quality.
Scott David A patents
Scott David A is listed as an inventor on 105 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Scott David A |
| Total patents | 105 |
| First publication | Oct 5, 2017 |
| Latest publication | Mar 10, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Crispr DNA targeting enzymes and systems
US-12553045-B2 · Feb 17, 2026 · US
CRISPR-associated systems and components
US-12522812-B2 · Jan 13, 2026 · US
Fused bicyclic egfr inhibitors and methods of use thereof
US-2025388573-A1 · Dec 25, 2025 · US
Dual-acting valve enabled catalyst bypass
US-2025361826-A1 · Nov 27, 2025 · US
Allosteric egfr inhibitors and methods of use thereof
US-2025340534-A1 · Nov 6, 2025 · US
Allosteric egfr inhibitors and methods of use thereof
US-2025340535-A1 · Nov 6, 2025 · US
CRISPR RNA targeting enzymes and systems and uses thereof
US-12460203-B2 · Nov 4, 2025 · US
CRISPR DNA targeting enzymes and systems
US-12460190-B2 · Nov 4, 2025 · US
Use of toll-like receptor 2 (tlr-2) agonist for modulating human immune response
US-2025325659-A1 · Oct 23, 2025 · US
Recent patents
Latest publications not already listed above.
Allosteric EGFR inhibitors and methods of use thereof
US-12391671-B2 · Aug 19, 2025 · US
Allosteric EGFR inhibitors and methods of use thereof
US-12377080-B2 · Aug 5, 2025 · US
Dual-acting valve enabled catalyst bypass
US-12331672-B2 · Jun 17, 2025 · US
Novel crispr dna and rna targeting enzymes and systems
US-2025154483-A1 · May 15, 2025 · US
Use of toll-like receptor 2 (TLR-2) agonist for modulating human immune response
US-12268739-B2 · Apr 8, 2025 · US
CRISPR DNA and RNA targeting enzymes and systems
US-12195770-B2 · Jan 14, 2025 · US
Novel crispr-associated transposon systems and components
US-2024409908-A1 · Dec 12, 2024 · US
Inhibitors of EGFR and methods of use thereof
US-12161649-B2 · Dec 10, 2024 · US
Cas12i2 fusion molecules and uses thereof
US-2024301446-A1 · Sep 12, 2024 · US
CRISPR-associated transposon systems and components
US-12054754-B2 · Aug 6, 2024 · US
CRISPR DNA targeting enzymes and systems
US-11976308-B2 · May 7, 2024 · US
Inhibitors of EGFR and/or HER2 and methods of use
US-11945816-B2 · Apr 2, 2024 · US
Crispr dna targeting enzymes and systems
US-2024101990-A1 · Mar 28, 2024 · US
Gene editing systems comprising a crispr nuclease and uses thereof
US-2024102007-A1 · Mar 28, 2024 · US
Compositions comprising a nuclease and uses thereof
US-2024093228-A1 · Mar 21, 2024 · US
CRISPR DNA targeting enzymes and systems
US-11912992-B2 · Feb 27, 2024 · US
Compositions comprising a nuclease and uses thereof
US-2024011031-A1 · Jan 11, 2024 · US
Novel crispr-associated systems and components
US-2023407281-A1 · Dec 21, 2023 · US
Dual-acting valve enabled catalyst bypass
US-2023374926-A1 · Nov 23, 2023 · US
CRISPR DNA targeting enzymes and systems
US-11795442-B2 · Oct 24, 2023 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Arbor Biotechnologies Inc | 60 |
| Dana Farber Cancer Inst Inc | 31 |
| Childrens Medical Center | 13 |
| Broad Inst Inc | 8 |
| Massachusetts Inst Technology | 8 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N2310/20 | 67 |
| C12N9/22 | 61 |
| C12N15/11 | 55 |
| C12N15/113 | 51 |
| C12N2800/80 | 36 |